新型冠状病毒肺炎患者发生DVT的危险因素分析
摘要
thrombosis,DVT)的危险因素。方法:本研究采用单中心回顾性病例对照研究方法,纳入重庆医科大学附属永川医
院2022年12月5日-2023年1月19日入院的COVID-19患者,以发生DVT为研究终点,根据下肢血管彩超将患者分
为DVT组与非DVT组,分析与患者发生DVT相关的可能危险因素。结果:单因素相关性检验结果显示,DVT组较
非DVT组更高龄,且更多入住监护室,住院日显著延长,PT活动度、白蛋白明显降低,白细胞计数、中性粒细胞数、
降钙素原、凝血酶原时间、D-二聚体、国际标准化比值显著升高。多元logistic回归分析显示,年龄、住院日、白细
胞计数、D-二聚体是新冠感染患者发生DVT的独立危险因素,年龄(OR,1.184;95% CI 1.091-1.286,P<0.001),
住院日(OR,1.141;95% CI 1.038-1.253,P=0.006),白细胞计数(OR,1.272;95% CI 1.007-1.606,P=0.043),D-
二聚体升高(OR,1.279;95% CI 1.055-1.550,P=0.012)。结论:高龄、长住院日、高D-二聚体、白细胞计数升高
是新型冠状病毒感染患者发生DVT的独立危险因素,为预防DVT提供一定的指导意义。
关键词
全文:
PDF参考
[1]SRIVASTAVA S, GARG I, BANSAL A, et al.
COVID-19 infection and thrombosis [J]. Clinica Chimica
Acta, 2020, 510: 344-346.
[2]中华人民共和国国家卫生健康委员会.新型冠状
病毒感染诊疗方案(试行第十版)[J].中华临床感染病杂
志,2023,16(1).
[3]张伟,张俊峰,王觅,等.成年烧伤患者深静脉血
栓的发生情况及危险因素[J].中华烧伤杂志,2020,36(1).
[4]REN Z, YUAN Y, QI W, et al. The incidence and
risk factors of deep venous thrombosis in lower extremities
following surgically treated femoral shaft fracture: a retrospective
case-control study [J]. JOURNAL OF ORTHOPAEDIC
SURGERY AND RESEARCH, 2021, 16.
[5]CAO J, LI S, MA Y, et al. Risk factors associated
with deep venous thrombosis in patients with different bedrest durations: A multi-institutional case-control study
[J]. INTERNATIONAL JOURNAL OF NURSINGSTUDIES, 2021, 114.
[6]刘婷,赵顺莹,王灵聪,等.脑出血患者静脉血栓
栓塞机械预防的证据总结[J].中华护理杂志,2019,54(6).
[7]ZHANG X, CAI Q, WANG X, et al. Current use of
rivaroxaban in elderly patients with venous thromboembolism
(VTE) [J]. Journal of thrombosis and thrombolysis, 2021, 52:
863-871.
[8]KHAN F, TRITSCHLER T, KAHN S R, et al.
Venous thromboembolism [J]. Lancet, 2021, 398: 64-77.
[9]邵长杰,杜晓颖,徐奎帅,等.住院天数影响全
膝关节置换术后下肢深静脉血栓形成[J].中华关节外科杂
志(电子版),2023,17(4).
[10]王彬,李霞,张玥,等.炎性细胞水平变化与深
静脉血栓形成中医证候分型关系探讨[J].山东中医药大学
学报,2006,30(2).
[11]王晓巍,权德海.白细胞计数与脑血栓形成预后
的关系(附92例临床报告)[J].吉林医学情报,1992,(10).
[12]MORESCO R N, VARGAS L C R, VOEGELI
C F, et al. D-dimer and its relationship to fibrinogen/
fibrin degradation products (FDPs) in disorders associated
with activation of coagulation or fibrinolytic systems [J].
JOURNAL OF CLINICAL LABORATORY ANALYSIS,
2003, 17: 77-79.
[13]KLOVAITE J, NORDESTGAARD B G,
TYBJAERG-HANSEN A, et al. Elevated Fibrinogen
Levels Are Associated with Risk of Pulmonary Embolism,
but Not with Deep Venous Thrombosis [J]. AMERICAN
JOURNAL OF RESPIRATORY AND CRITICAL CARE
MEDICINE, 2013, 187.
[14]OLSON J D. D-dimer: An Overview of
Hemostasis and Fibrinolysis, Assays, and Clinical Applications
[J]. ADVANCES IN CLINICAL CHEMISTRY, VOL 69,
2015, 69.
[15]OBRADOVIC S, DZUDOVIC B, RUSOVIC
S, et al. Gender-related differences in clinical presentation,
electrocardiography signs, laboratory markers and
outcome in patients with acute pulmonary embolism [J].
VOJNOSANITETSKI PREGLED, 2016, 73.
[16]STEIN P, HULL R, PATEL K, et al. D-dimer
for the exclusion of acute venous thrombosis and pulmonary
embolism - A systematic review [J]. ANNALS OF
INTERNAL MEDICINE, 2004, 140.
Refbacks
- 当前没有refback。